309 skills · sorted by relevance
Estimate the effort of the current, given, or all unestimated task plans as T-shirt sizes (XS, S, M, L, XL) of expected human time, and store it in the "Effort:" frontmatter key, or calibrate the estimation against the actual human time of the finished tasks. Use when the user wants to "estimate", "size", or "gauge the effort" of a "task" or "plan", or to "calibrate" the effort estimation.
The English summary is being prepared. Showing the original description.
Fit cognitive drift-diffusion models (Ratcliff DDM) to reaction time and accuracy data with parameter estimation (drift rate, boundary separation, non-decision time), model comparison, and parameter recovery validation. Use when modeling binary decision-making with reaction time data, estimating cognitive parameters from experimental data, comparing sequential sampling model variants, or decomposing speed-accuracy tradeoff effects into latent cognitive components.
The English summary is being prepared. Showing the original description.
Create a Work Breakdown Structure (WBS) and WBS Dictionary from project charter deliverables. Covers hierarchical decomposition, WBS coding, effort estimation, dependency identification, and critical path candidates. Use after a project charter is approved, when planning a classic or waterfall project with defined deliverables, breaking a large initiative into manageable work packages, or establishing a basis for effort estimation and resource planning.
The English summary is being prepared. Showing the original description.
Feed actual task results back into agent memory for calibration. Compares predicted vs actual outcomes, records accuracy scores, and tracks estimation quality, prediction quality, and decision quality over time to improve future agent performance.
The English summary is being prepared. Showing the original description.
Set up, format, fix, and clean up LaTeX regression and estimation tables in empirical economics or finance papers. Use when (a) creating a .tex, results.tex, main.tex, or preamble to display regression or estimation output from Python (pyfixest), Stata, or R — including any mention of estout, esttab, estauto, estwide, or table fragments; (b) formatting or repairing estout-style regression tables that overflow the right margin, have cramped or boxed notes, misaligned columns, or poor significance stars, or when asked to match a reference paper, make the note fill the table width, or choose among \estwide, \estauto, and landscape layouts; (c) diagnosing "Misplaced \omit" errors from \input-ed table fragments inside tabular environments. Covers \@@input, \estwide, \estauto, \estautoLT, \specialcell, \sym, minipage notes below tabulars, and the convert-and-verify workflow. Do NOT trigger for general LaTeX documents like beamer presentations, problem sets, letters, or CVs.
The English summary is being prepared. Showing the original description.
Audit a quoting or estimation system -- analyze labor hour estimation accuracy, material take-off completeness, pricing rule engines, markup and margin optimization, good-better-best tiered pricing, and quote-to-close win rates.
The English summary is being prepared. Showing the original description.
Audit a mineral resource estimation system -- evaluate drillhole database integrity and QA/QC (CRMs, blanks, duplicates, umpire checks), geological and domain modeling quality, variogram analysis and grade interpolation methods (ordinary kriging, indicator kriging, IDW.
The English summary is being prepared. Showing the original description.
Use for Fermi estimation, or when a rough number is needed fast: "roughly how many...", "ballpark the cost", "estimate capacity or market size", "is this even feasible?". Decomposes, uses ranges and sanity-checks. Skip when exact data is available or a precise calculation is wanted.
The English summary is being prepared. Showing the original description.
Controls error rates across thousands of simultaneous tests in genomics discovery using false-discovery-rate methods (Benjamini-Hochberg 1995; Benjamini-Yekutieli 2001 for arbitrary dependence; Storey q-value with pi0 estimation; local FDR; independent filtering Bourgon 2010; covariate-weighted FDR via IHW Ignatiadis 2016), plus family-wise error control (Bonferroni, Holm) and the GWAS genome-wide threshold. Covers the FDR-versus-FWER choice as the discovery-versus-confirmatory distinction, the dependence assumptions behind BH (PRDS) versus BY, pi0 estimation, the independent-filtering and false-coverage-rate traps, and reproducibility ranking via IDR (Li 2011). Use when correcting p-values from genome-wide tests, choosing between BH/BY/q-value/Bonferroni, setting an FDR threshold, applying IHW or independent filtering, or interpreting q-values. For confirmatory trials with few pre-specified endpoints (closed testing, graphical/gatekeeping), see clinical-biostatistics/multiplicity-graphical.
The English summary is being prepared. Showing the original description.
Designs adaptive clinical trials including group-sequential (O'Brien-Fleming, Pocock, Lan-DeMets spending), sample-size re-estimation (blinded Friede-Kieser, unblinded Cui-Hung-Wang, Mehta-Pocock promising zone), seamless Phase 2/3 with treatment-arm selection, population enrichment, and response-adaptive randomisation. Covers FDA 2019 Final Adaptive Designs Guidance, FDA 2022 Master Protocols, and ICH E20 Step 2b/3 draft (June 2025, NOT final). Use when planning interim analyses, sample-size re-estimation, or master/platform-trial designs.
The English summary is being prepared. Showing the original description.
Pre-ticket Fibonacci sizing for a paste-mode batch of user stories. Default mode is advisory-only (writes a Story Sizing Report). Opt-in `--auto-create` delegates ticket creation to mk:jira-issue + mk:jira-collaborate with mandatory dry-run + single batch confirmation gate. NOT for single-ticket estimation (mk:jira-estimator); NOT for sprint capacity (mk:planning-engine).
The English summary is being prepared. Showing the original description.
Expert-level computer vision for robotics covering camera models, feature detection, object detection, pose estimation, visual SLAM, and deep learning for perception.
The English summary is being prepared. Showing the original description.
Expert-level construction management covering project planning, scheduling, cost estimation, procurement, quality control, safety, and contract administration.
The English summary is being prepared. Showing the original description.
Estimate AI-assisted and hybrid human+agent development work with research-backed PERT statistics and calibration feedback loops
The English summary is being prepared. Showing the original description.
Designs adaptive clinical trials including group-sequential (O'Brien-Fleming, Pocock, Lan-DeMets spending), sample-size re-estimation (blinded Friede-Kieser, unblinded Cui-Hung-Wang, Mehta-Pocock promising zone), seamless Phase 2/3 with treatment-arm selection, population enrichment, and response-adaptive randomisation. Covers FDA 2019 Final Adaptive Designs Guidance, FDA 2022 Master Protocols, and ICH E20 Step 2b/3 draft (June 2025, NOT final). Use when planning interim analyses, sample-size re-estimation, or master/platform-trial designs.
The English summary is being prepared. Showing the original description.
Controls error rates across thousands of simultaneous tests in genomics discovery using false-discovery-rate methods (Benjamini-Hochberg 1995; Benjamini-Yekutieli 2001 for arbitrary dependence; Storey q-value with pi0 estimation; local FDR; independent filtering Bourgon 2010; covariate-weighted FDR via IHW Ignatiadis 2016), plus family-wise error control (Bonferroni, Holm) and the GWAS genome-wide threshold. Covers the FDR-versus-FWER choice as the discovery-versus-confirmatory distinction, the dependence assumptions behind BH (PRDS) versus BY, pi0 estimation, the independent-filtering and false-coverage-rate traps, and reproducibility ranking via IDR (Li 2011). Use when correcting p-values from genome-wide tests, choosing between BH/BY/q-value/Bonferroni, setting an FDR threshold, applying IHW or independent filtering, or interpreting q-values. For confirmatory trials with few pre-specified endpoints (closed testing, graphical/gatekeeping), see clinical-biostatistics/multiplicity-graphical.
The English summary is being prepared. Showing the original description.
Controls error rates across thousands of simultaneous tests in genomics discovery using false-discovery-rate methods (Benjamini-Hochberg 1995; Benjamini-Yekutieli 2001 for arbitrary dependence; Storey q-value with pi0 estimation; local FDR; independent filtering Bourgon 2010; covariate-weighted FDR via IHW Ignatiadis 2016), plus family-wise error control (Bonferroni, Holm) and the GWAS genome-wide threshold. Covers the FDR-versus-FWER choice as the discovery-versus-confirmatory distinction, the dependence assumptions behind BH (PRDS) versus BY, pi0 estimation, the independent-filtering and false-coverage-rate traps, and reproducibility ranking via IDR (Li 2011). Use when correcting p-values from genome-wide tests, choosing between BH/BY/q-value/Bonferroni, setting an FDR threshold, applying IHW or independent filtering, or interpreting q-values. For confirmatory trials with few pre-specified endpoints (closed testing, graphical/gatekeeping), see clinical-biostatistics/multiplicity-graphical.
The English summary is being prepared. Showing the original description.
Designs adaptive clinical trials including group-sequential (O'Brien-Fleming, Pocock, Lan-DeMets spending), sample-size re-estimation (blinded Friede-Kieser, unblinded Cui-Hung-Wang, Mehta-Pocock promising zone), seamless Phase 2/3 with treatment-arm selection, population enrichment, and response-adaptive randomisation. Covers FDA 2019 Final Adaptive Designs Guidance, FDA 2022 Master Protocols, and ICH E20 Step 2b/3 draft (June 2025, NOT final). Use when planning interim analyses, sample-size re-estimation, or master/platform-trial designs.
The English summary is being prepared. Showing the original description.
Decompose an unknown quantity into 3-5 estimable factors and produce a defensible order-of-magnitude answer without needing precise data. Load when the user needs to size something without data — market size, resource requirements, effort estimates, user numbers, costs — or when a decision is blocked by "we don't know the numbers". Also triggers on "ballpark this", "rough estimate", "how big is this market", "how long would this take", "how many users", or when deep-thinking diagnoses a sizing/estimation frame. The goal is not precision — it is a defensible answer that enables a decision to be made. Based on Enrico Fermi's estimation method.
The English summary is being prepared. Showing the original description.
Controls error rates across thousands of simultaneous tests in genomics discovery using false-discovery-rate methods (Benjamini-Hochberg 1995; Benjamini-Yekutieli 2001 for arbitrary dependence; Storey q-value with pi0 estimation; local FDR; independent filtering Bourgon 2010; covariate-weighted FDR via IHW Ignatiadis 2016), plus family-wise error control (Bonferroni, Holm) and the GWAS genome-wide threshold. Covers the FDR-versus-FWER choice as the discovery-versus-confirmatory distinction, the dependence assumptions behind BH (PRDS) versus BY, pi0 estimation, the independent-filtering and false-coverage-rate traps, and reproducibility ranking via IDR (Li 2011). Use when correcting p-values from genome-wide tests, choosing between BH/BY/q-value/Bonferroni, setting an FDR threshold, applying IHW or independent filtering, or interpreting q-values. For confirmatory trials with few pre-specified endpoints (closed testing, graphical/gatekeeping), see clinical-biostatistics/multiplicity-graphical.
The English summary is being prepared. Showing the original description.
Designs adaptive clinical trials including group-sequential (O'Brien-Fleming, Pocock, Lan-DeMets spending), sample-size re-estimation (blinded Friede-Kieser, unblinded Cui-Hung-Wang, Mehta-Pocock promising zone), seamless Phase 2/3 with treatment-arm selection, population enrichment, and response-adaptive randomisation. Covers FDA 2019 Final Adaptive Designs Guidance, FDA 2022 Master Protocols, and ICH E20 Step 2b/3 draft (June 2025, NOT final). Use when planning interim analyses, sample-size re-estimation, or master/platform-trial designs.
The English summary is being prepared. Showing the original description.
Plan inventory for retailers with multiple stores by choosing demand forecasts, calculating stock buffers and replenishment quantities, and assessing promotions. Account for demand drops after promotions, supplier lead times, and seasonal markdown timing.
Work on advanced RuView sensing with signals from multiple WiFi nodes. Explore position estimation, three-dimensional occupancy reconstruction, changes in movement patterns over time, and defenses against suspicious signals, with guidance on implementation modules and validation.
Train and evaluate models that estimate human poses from WiFi signals. Compare results against a model that always predicts the average pose, check for data leakage, and report measured improvements with clear evaluation conditions.